Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS OCTOBER ISSUE PUBLISHED
  • OCTOBER 2020 Issue has been successfully launched on 1 October 2020.

Abstract

AN OVERVIEW ON INTERRELATIONSHIP BETWEEN QUALITY BY DESIGN (QbD) & SIX SIGMA

Kapil Joshi*, Abhay Asthana, Subhash Pande, Gyati Shilakari Asthana, Kishan Singh and Garima Goomber

ABSTRACT

Quality is primary attribute to any industry and its products manufactured. Quality by design (QbD) and six sigma is the modern approach for pharmaceutical quality development and management. This paper gives an idea about the interrelationship between pharmaceutical QbD and six sigma and describes the use of both (QbD and six sigma) to ensure the quality of pharmaceuticals. The use of QbD and six sigma principles (using DMAIC and DMADV) during product development provide opportunities to facilitate innovation and continual improvement throughout the product lifecycle which can increase the efficiency of manufacturing processes; reduce the defects and product non-compliance, resulting in cost savings for pharmaceutical companies. QbD and six sigma can also be helpful for the use of innovative technologies and enhance the use of new approaches to perform process validation like continuous process verification. QbD is a systematic approach and has the potential to make a positive contribution towards drug development and six sigma is a project oriented, statistical approach for reducing variability, removing defects and eliminating waste from products and processes.

Keywords: Quality by Design, Six sigma, Critical Quality Attributes (CQAs), DMAIC (Define, Measure, Analyze, Improve, Control), DMADV (Define, Measure, Analyze, Design, Verify).


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More